Recent research has supported that human cervical cancer proto-oncogene (HCCR) is a specific and sensitive biomarker independent of serum alpha-fetoprotein (AFP) for the diagnosis of HCC [3–5]. The gene discussed is LETMD1; the disease is hepatocellular carcinoma.